Literature DB >> 7677172

Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma.

H C Ee1, T Erler, P S Bhathal, G P Young, R J James.   

Abstract

Cancers share many similarities in growth patterns, cellular morphology, and oncofetal antigen expression with embryonic tissue. To better understand the mechanisms underlying malignant transformation and its relationship to developmental processes, we studied the expression of Cdx-2, an intestinal epithelium-specific homeodomain protein, in colorectal adenoma and carcinoma. By immunohistochemistry with a polyclonal Cdx-2 antibody we have shown that Cdx-2 expression is markedly reduced in the later stages of human colorectal carcinogenesis, namely, high grade dysplasia and invasive carcinoma. The same findings occur in 1,2-dimethylhydrazine-induced rat colorectal tumors, confirming the parallels between the rat model and the human disease. As homeodomain proteins play major roles in directing the regionalization of body parts and in organogenesis and cellular phenotypic specification, a reduction of Cdx-2 expression in the late stages of colorectal carcinogenesis may reflect a concomitant deviation of the neoplastic tissue from the normal intestinal epithelial phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7677172      PMCID: PMC1870974     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Structure of the murine homeobox gene cdx-2. Expression in embryonic and adult intestinal epithelium.

Authors:  R James; T Erler; J Kazenwadel
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

2.  Hox11 controls the genesis of the spleen.

Authors:  C W Roberts; J R Shutter; S J Korsmeyer
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

Review 3.  Tumour markers in oncology: past, present and future.

Authors:  H Magdelénat
Journal:  J Immunol Methods       Date:  1992-06-24       Impact factor: 2.303

4.  Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas.

Authors:  C W Schweinfest; K W Henderson; S Suster; N Kondoh; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice.

Authors:  D A Dedera; E K Waller; D P LeBrun; A Sen-Majumdar; M E Stevens; G S Barsh; M L Cleary
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

6.  E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.

Authors:  M P Kamps; D Baltimore
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

7.  Expression of homeobox-containing genes in primary and metastatic colorectal cancer.

Authors:  G De Vita; P Barba; N Odartchenko; J C Givel; G Freschi; G Bucciarelli; M C Magli; E Boncinelli; C Cillo
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

8.  HOX gene expression in normal and neoplastic human kidney.

Authors:  C Cillo; P Barba; G Freschi; G Bucciarelli; M C Magli; E Boncinelli
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

9.  Butyrate production from dietary fibre and protection against large bowel cancer in a rat model.

Authors:  A McIntyre; P R Gibson; G P Young
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

10.  Cancer, retrodifferentiation, and the myth of Faust.

Authors:  J Uriel
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

View more
  49 in total

1.  Homeobox genes: going for growth.

Authors:  R J Playford
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Stem cell in gastrointestinal structure and neoplastic development.

Authors:  M Brittan; N A Wright
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Another important function for an old friend! The role of iron in colorectal carcinogenesis.

Authors:  J R Butterworth
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells.

Authors:  Fairouz Benahmed; Isabelle Gross; Dominique Guenot; Frédéric Jehan; Elisabeth Martin; Claire Domon-Dell; Thomas Brabletz; Michèle Kedinger; Jean-Noël Freund; Isabelle Duluc
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

5.  The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.

Authors:  C Bonhomme; I Duluc; E Martin; K Chawengsaksophak; M-P Chenard; M Kedinger; F Beck; J-N Freund; C Domon-Dell
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

6.  Homeobox protein CDX2 reduces Cox-2 transcription by inactivating the DNA-binding capacity of nuclear factor-kappaB.

Authors:  Hiroyuki Mutoh; Hiroko Hayakawa; Hirotsugu Sakamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

7.  Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.

Authors:  Bon Q Trinh; Song Yi Ko; Nicolas Barengo; Shiaw-Yih Lin; Honami Naora
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

8.  Transcription factor PDX-1 in human colorectal adenocarcinoma: a potential tumor marker?

Authors:  Nikiforos Ballian; Shi-He Liu; Francis-Charles Brunicardi
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

9.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

Review 10.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.